Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin plus alpha-lipoic acid vs alpha-lipoic acid for burning mouth syndrome
ChiCTR2500115337Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of melatonin in glossodynia (BMS) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Visual Analogue Scale (VAS) score for oral burning pain. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
glossodynia (BMS)
Beyond the preview
Go deeper on ChiCTR2500115337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115337.